Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency?


Allogeneic hematopoietic stem cell transplant (HSCT) is used to treat increasing numbers of malignant and non-malignant disorders. Despite significant advances in improved human leukocyte antigens-typing techniques, less toxic conditioning regimens and better supportive care, resulting in improved clinical outcomes, acute graft-versus-host disease (aGvHD… (More)
DOI: 10.3389/fimmu.2017.00328


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.